Compare W W Grainger Inc (GWW) vs Regeneron Pharmaceuticals Inc (REGN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
W W Grainger Inc vs Regeneron Pharmaceuticals Inc — how do they compare? W W Grainger Inc trades at $1,300.82 (market cap $61.32B), while Regeneron Pharmaceuticals Inc trades at $796.38 (market cap $82.06B). The key difference: Regeneron Pharmaceuticals Inc is the larger of the two by market cap, and W W Grainger Inc pays the higher dividend (0.77%). Which is the better fit depends on your goals.
| GWW | REGN | |
|---|---|---|
Market Cap | $61.32B | $82.06B |
Sector | Technology | Health |
52-Week High | $1.40K | $812.27 |
52-Week Low | $918.18 | $555.51 |
Enterprise Value | $63.53B | $76.77B |
Dividend Yield | 0.77% | 0.47% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About W W Grainger Inc
Grainger is a leading broad-line distributor of maintenance, repair, and operating (MRO) products. It serves millions of customers worldwide through an integrated network of branches and digital platforms.
Read more on GWW →About Regeneron Pharmaceuticals Inc
Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including Eylea, approved for wet age-related macular degeneration and other eye diseases
Read more on REGN →
